These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15794538)

  • 21. Treatment of primary writing tremor with botulinum toxin type a injections: report of a case series.
    Papapetropoulos S; Singer C
    Clin Neuropharmacol; 2006; 29(6):364-7. PubMed ID: 17095901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum neurotoxin A: an unusual systemic effect.
    Howell K; Selber P; Graham HK; Reddihough D
    J Paediatr Child Health; 2007 Jun; 43(6):499-501. PubMed ID: 17535186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Botulinum toxin management of upper facial rhytidosis and blepharospasm.
    Seiff SR; Zwick OM
    Otolaryngol Clin North Am; 2005 Oct; 38(5):887-902. PubMed ID: 16214565
    [No Abstract]   [Full Text] [Related]  

  • 24. In-office transnasal esophagoscope-guided botulinum toxin injection of the lower esophageal sphincter.
    Rees CJ
    Curr Opin Otolaryngol Head Neck Surg; 2007 Dec; 15(6):409-11. PubMed ID: 17986880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum toxin type A for the treatment of headache: con.
    Welch KM
    Headache; 2004 Sep; 44(8):831-3. PubMed ID: 15330835
    [No Abstract]   [Full Text] [Related]  

  • 26. Successful treatment of a postpolio tinnitus with type a botulinum toxin.
    Scolozzi P; Carrera E; Jaques B; Kuntzer T
    Laryngoscope; 2005 Jul; 115(7):1288-90. PubMed ID: 15995523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Botulinum toxin type A in the treatment of sialorrhea in Parkinson's disease.
    Melo A; Rodrigues B; Nóbrega AC
    J Am Geriatr Soc; 2009 Jan; 57(1):180; author reply 180-1. PubMed ID: 19170803
    [No Abstract]   [Full Text] [Related]  

  • 28. Botox therapy for refractory chronic migraine.
    Conway S; Delplanche C; Crowder J; Rothrock J
    Headache; 2005 Apr; 45(4):355-7. PubMed ID: 15836573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Botulinum toxin improves dysphagia associated with multiple sclerosis.
    Restivo DA; Marchese-Ragona R; Patti F; Solaro C; Maimone D; Zappalá G; Pavone A
    Eur J Neurol; 2011 Mar; 18(3):486-90. PubMed ID: 20731706
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botulinum toxin a treatment in chronic daily headache.
    Cutrer FM
    Headache; 2005 Apr; 45(4):270-1. PubMed ID: 15836560
    [No Abstract]   [Full Text] [Related]  

  • 31. Botulinum toxin A treatment for contouring of the lower leg.
    Han KH; Joo YH; Moon SE; Kim KH
    J Dermatolog Treat; 2006; 17(4):250-4. PubMed ID: 16971324
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuromyotonia in a muscle flap producing a convulsing breast: successful treatment with botulinum toxin.
    Schwartz MS; Wren DR; Filshie J
    Mov Disord; 1998 Jan; 13(1):188-90. PubMed ID: 9452354
    [No Abstract]   [Full Text] [Related]  

  • 33. Botulinum toxin type A as an adjuvant treatment modality for extensive Hailey-Hailey disease.
    Koeyers WJ; Van Der Geer S; Krekels G
    J Dermatolog Treat; 2008; 19(4):251-4. PubMed ID: 18629693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Botulinum toxin A injection for children with spastic cerebral palsy.
    YaJie W; BaoQin G
    Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907
    [No Abstract]   [Full Text] [Related]  

  • 35. The successful use of botulinum toxin for the treatment of nasal hyperhidrosis.
    Geddoa E; Balakumar AK; Paes TR
    Int J Dermatol; 2008 Oct; 47(10):1079-80. PubMed ID: 18986362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Criteria and best clinical practice guidelines for first intradetrusor injection of botulinum toxin type A to treat neurogenic detrusor overactivity].
    Perrouin-Verbe B; Ruffion A; Gamé X; Denys P; Kerdraon J; Karsenty G; de Sèze M; Haab F; Saussine C; Soler JM; Amarenco G; Chartier-Kastler E
    Prog Urol; 2009 Jun; 19(6):372-82. PubMed ID: 19467455
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Botulinum toxin: from life-threatening disease to novel medical therapy.
    Mahajan ST; Brubaker L
    Am J Obstet Gynecol; 2007 Jan; 196(1):7-15. PubMed ID: 17240220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paradoxical use of frontalis muscle and the possible role of botulinum a toxin in permanent motor relearning.
    Ben Simon GJ; Blaydon SM; Schwarcz RM; Nakra T; Goldberg RA; McCann JD
    Ophthalmology; 2005 May; 112(5):918-22. PubMed ID: 15878076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ocular motility disturbances in Graves' disease with botulinum toxin A.
    Stiglmayer N; Lesin M; Juri J; Ivanisević M; Boić L; Rogosić V
    Coll Antropol; 2005; 29 Suppl 1():41-6. PubMed ID: 16193675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Botulinum toxin A for the management of vulvodynia.
    Yoon H; Chung WS; Shim BS
    Int J Impot Res; 2007; 19(1):84-7. PubMed ID: 16728964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.